Arvinas’ ‘Protac’ breast cancer drug cleared by FDA
Summary
Known as Veppanu, the drug is the first of its kind to get to market. But Arvinas and partner Pfizer are still searching for a new partner to sell it.
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.